Role of novel antiresorptive agents for the prevention and treatment of osteoporosis.
Meier
C A
CA
Département de Médecine Interne, Hôpital Cantonal Universitaire de Genève, Geneva, Switzerland.
D019386:Alendronate / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000517:prevention & control*; D010880:Piperidines / Q000627:therapeutic use; D020849:Raloxifene Hydrochloride
D004965:Estrogen Antagonists; D010880:Piperidines; D020849:Raloxifene Hydrochloride; D019386:Alendronate